profit from every $100 of sales.
$0$100
StoneBridge Acquisition II
$10.45+0.00% today
+4.0% in 1 year
1-year low $10.031-year high $10.56
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
StoneBridge Acquisition II vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| StoneBridge Acquisition II | No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads StoneBridge Acquisition II's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2025 |
|---|---|
| 0 | |
| – | |
| -0 | |
| -0 | |
| 0 | |
| – | |
| – | |
| – | |
| – |
Balance sheet
| In millions of USD | 2025 |
|---|---|
| Total assets | 59 |
| Cash | 1 |
| Total debt | 0 |
| Total liabilities | 0 |
| 59 | |
| – | |
| -0.3% | |
| 0.5% |
Cash flow
| In millions of USD | 2025 |
|---|---|
| -0 | |
| – | |
| -0 | |
| Dividends paid | – |
| – | |
| – |
Valuation
- –
- –
- 3.61
- 31.1×
- 0.0×
- –
- –
- -0.6%
- -0.4%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -0.1%
- -11.5%
- -45.8%
- -0.1%
- -0.1%
- –
Growth
- –
- −62.2%
- +54.5%
- –
- −46.4%
Financial health
- -8.3×
- 0.00
- 0.0%
- –
- 12.21
- 12.21
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 14%of 668
Bottom 9%of 523
Bottom 22%of 938
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
22No pass
Benjamin Graham
40No pass
Philip Fisher
21No pass
Peter Lynch
24No pass
Joel Greenblatt
0No pass
Charlie Munger
30No pass
Terry Smith
19No pass
Questions about StoneBridge Acquisition II
Is StoneBridge Acquisition II a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the StoneBridge Acquisition II AI analysis
What does StoneBridge Acquisition II do?
StoneBridge Acquisition II Corp focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses in the Asia-Pacific, Europe, the Middle East, and Africa. It is in Shell Companies.
Does StoneBridge Acquisition II pay a dividend?
No. StoneBridge Acquisition II does not pay a dividend at the moment.
Is StoneBridge Acquisition II stock halal?
Questionable. StoneBridge Acquisition II sits in a grey zone: scholars disagree about its industry. How we check
How has StoneBridge Acquisition II stock done over the past year?
Up 4.0% over the past twelve months, to $10.45. It traded between $10.03 and $10.56, close to its high.
Who are StoneBridge Acquisition II's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with StoneBridge Acquisition II's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.